Artificial Intelligence | Machine Learning DeepCure | AI Drug Discovery Revolution


Consumer, Biotechnology, Drug Discovery, Deep Learning, Computational Chemistry, Cloud Computing Boston, MA, United States

DeepCure

Artificial Intelligence | Machine Learning


DeepCure | AI Drug Discovery Revolution

DeepCure

Biotechnology, Drug Discovery, Deep Learning, Computational Chemistry, Cloud Computing


Boston, MA, United States

Deepcure was founded to accelerate breakthrough science, developed by world-leading AI engineers, data scientists, and biologists. Using an end-to-end drug discovery platform and automated robotic wet lab, the Company is developing a novel pipeline of precision small molecules across many different therapeutic indications. DeepCure’s founding team includes some of the industry’s preeminent researchers and technologists. Our vision is to use AI-driven discovery to create better small molecules therapeutics and faster cures for every disease-relevant protein target.

DeepCure is transforming the field of small-molecule drug discovery, by delivering better drugs in a faster and more affordable way. At DeepCure, we reimagine the discovery pipeline using our AI platform to search the enormous chemical space with state-of-the-art accuracies. By combining the power of our Deep Learning algorithms, Cloud Computing infrastructure, and proprietary database of one Trillion chemistries, DeepCure's platform finds drug candidates that deliver improved value to patients. Our mission is to uncover new chemical horizons and enable discovery of "improbable" small-molecule therapeutics, delivering immense value to patients in need. DeepCure's AI algorithms analyze a trillion drug candidates from our proprietary virtual library and accurately point out the most promising ones while accounting for the dynamic nature of the target and optimizing the required ADMET properties.

 

B2C

1 to 25

Series A

47,000,000

Scaling Up

2018

 
 

Healthcare
Biotechnology

Cost-Effective and Faster

Reduce Operational Cost
Increase Efficiency
Increase Productivity

 
 

Service

No

Active

 
 

   Machine Learning


Drug Discovery

Drug Discovery


N/A

 

   Software


React

React

K8s

K8s

Apache Spark

Apache Spark

DynamoDB

DynamoDB

AWS

AWS

AWS Athena

AWS Athena

Python

Python


Deep Learning Algorithm

Deep Learning Algorithm

Machine Learning Algorithm

Machine Learning Algorithm

 
 

Nov 2021

  • DeepCure Raised $40m Series A, led by Morningside Venture

Oct 2021

  • DeepCure Joins MIT STEX25 Accelerator
 
 

View All

View All AI/ML Jobs

Senior Machine Learning Scientist

Boston, MA

Lab Manager

Rehovot, Remote

Software Engineer

Athens, Remote

Site Reliability Engineer

Athens, Remote

Associate Director / Director DMPK

Boston, MA

 

AI/ML Professionals

Want to work at DeepCure?

We can introduce you to the right person at DeepCure

Talk to our Talent Team

 

1

1

$40M

Company was founded 2018 and it took almost 3 years (Nov 2021) to raise first external round

 
 

Date

Round

$ Raised

Investors

11/08/2021

Series A

$40M

Sapir Venture Partners

Date : 11/08/2021

Round: Series A

$ Raised: $40M

Investors: Sapir Venture Partners

 

Investors

Interested in researching DeepCure?

We have plenty of data and we can help. Our deal sourcing platform can help you perform more research about DeepCure

Request a Demo - Deal Souring Platform

 
Thrasyvoulos Karydis


Thrasyvoulos Karydis
Co-Founder and CTO

Kfir Schreiber


Kfir Schreiber
Chief Executive Officer

Steven Ferrara


Steven Ferrara
Associate Director, Medicinal Chemistry

 Michelle Sidor


Michelle Sidor
Director of Biology

 Marino Convertino


Marino Convertino
Principal Scientist, Computational Chemistry

 
 

Potential Customers

Interested in what they do or partnership?

Learn more about how they work

Schedule a Call w/ DeepCure